Skip to content

MRI-Based Collateral Flow Assessment for Thrombectomy Selection Within 6-24 Hours: A Multicenter Randomized Clinical Trial

Study for application of simple preoperative evaluation of thrombectomy for acute cerebral infarction based on magnetic resonance imaging

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000031829
Enrollment
Unknown
Registered
2020-04-11
Start date
2020-04-20
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Stroke

Interventions

MRI Group:The indication for endovascular therapy was determined solely based on MR imaging findings. Patients exhibiting FVH-DWI mismatch on multimodal MRI received endovascular therapy plus optimal
Perfusion Group:Indications for endovascular therapy were determined exclusively based on perfusion imaging findings. Patients meeting the DEFUSE 3-defined perfusion mismatch criteria (ischemic core v

Sponsors

Tianjin Huanhu Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age of 18 years or older; 2. Anterior circulation LVO (internal carotid artery, or middle cerebral arteries (MCA)M1, M2 proximal segment) confirmed by computed tomographic angiography (CTA)/ magnetic resonance angiography (MRA); 3. NIHSS score =6 at the time of randomization; 4. Time from stroke onset to randomization within 6-24 hours; 5. Pre-stroke mRS score 0-2; 6. Completed MRI and perfusion imaging or could cooperate to complete MRI and/or perfusion imaging; 7. Signed informed consent.

Exclusion criteria

Exclusion criteria: 1. ASPECTS score 3 or PPT > 3 times normal); 5. Active hemorrhage or preexisting tendency to hemorrhage; 6. Presence of signs of cardiac, hepatic or renal failure; 7. Participation in other interventional randomized clinical trial that may confound the outcome assessment of the trial; 8. Life expectancy < 1 year; 9. A stroke attack with epilepsy that prevents an accurate NIHSS score from being obtained; 10. Multiple large vessel occlusion; 11. Other circumstances that the investigator considers inappropriate for participation in the trial (such as violation of guidelines or institutional processing principles during the screening process); 12. CTA/MRA shows vascular anatomy is severely tortuous, has an anatomic variation that would preclude the navigation of the thrombectomy devices to the target vessel.

Design outcomes

Primary

MeasureTime frame
Functional independence(modified Rankin Scale(mRS) 0-2);

Secondary

MeasureTime frame
NIHSS scores at 24h after randomization;NIHSS scores at 7 days or at discharge (whichever was earlier) ;Proportion of patients functionally independent of daily activities (defined as Barthel index >95) ;Infarct volume;Repass rate;EQ-5D evaluates the quality of health survival;Length of hospitalization;Symptomatic intracranial hemorrhage;Any intracranial hemorrhage;Mortality rate;

Countries

China

Contacts

Public ContactWei Ming

Tianjin Huanhu Hospital

drweiming@163.com+86 135 0218 2903

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026